1 application named OMILUN
| Application | Class | Applicant | Filed | Advertised | Opposition |
|---|---|---|---|---|---|
| 5471805OMILUN | 3Cosmetics and cleaning | Individual applicant (Y. Z.) | 1 June 2022 | No. 208028 November 2022 | closed28 March 2023 |
Goods and services claimed
Class 3: Cosmetics and cleaning · application 5471805
Polishing powder; False eyelashes; Varnish-removing preparations; False nails; Nail care preparations; Cosmetic preparations for skin care; Adhesives for affixing false eyelashes; Nail art stickers; Cotton wool for cosmetic purposes; Cosmetic pencils; Make-up removing preparations; Ethereal oils; Beauty masks; Facial cleanser; Lipsticks; Perfumes; Cosmetic kits; Colorants for toilet purposes; Skin whitening creams
Proposed to be used · Delhi office · full journal entry
Can I use or register "OMILUN"?
For the same or related goods, probably not. In class 3 (cosmetics and cleaning), a new application for an identical or confusingly similar name is likely to be objected to by the Registry under Section 11 of the Trade Marks Act, 1999, or opposed by the earlier applicant. Closely related classes, such as class 5 (pharmaceuticals and health), class 21 (household and kitchenware), class 44 (medical, beauty and agricultural services) and class 35 (advertising, business and retail), carry the same risk.
For unrelated goods, often yes. The same word can be registered by different owners in different classes when the goods are unrelated and the earlier mark is not well known. "OMILUN" appears in 1 class; the other 44 may still be open, subject to a search.
A small change rarely helps. Adding a word, changing a letter or using a logo does not avoid conflict on its own: marks are compared as a whole, by look, sound and idea.
Similar names in the journal
- Omilightsimilar spelling · class 35 (Advertising, business and retail) · Proprietor of Rgs Industries
- OMILIXsimilar spelling · class 5 (Pharmaceuticals and health) · Human Biolife India Private Limited
- OMILEXsimilar spelling · class 5 (Pharmaceuticals and health) · Masters Health Innovations Private Limited
- OMILIFTsimilar spelling · class 5 (Pharmaceuticals and health) · Individual applicant (S. K.)
- OMILARsimilar spelling · class 5 (Pharmaceuticals and health) · Stellar Biolabs
- OMILLEYUM logosimilar spelling · class 30 (Staples, spices and confectionery) · Individual applicant (A.)
Matched by spelling and containment across every issue since August 2021. Our free report and Brand Watch also check sounds-alike names.
Questions about OMILUN
Is OMILUN a registered trademark?
OMILUN has been applied for and advertised in the Trade Marks Journal (1 application, latest on 28 November 2022). Advertisement means the Registry accepted the application; it is registered only if no opposition succeeds within four months of the journal date. The journal does not record the later outcome, so check the live register before relying on it.
Who applied for the OMILUN trademark?
The application was filed by an individual applicant. We do not publish individuals' names.
Can I register a trademark similar to OMILUN?
Not for the same or related goods in class 3: a confusingly similar name is likely to be refused or opposed. For unrelated goods it may be possible after a search. Ask for a free availability report before you file.
What does "advertised" mean? Read trademark status meanings, how long registration takes and how to run a trademark search.
Source and limits. Built from the Trade Marks Journal published by the Registrar of Trade Marks (a public record), issues from August 2021 onwards, as advertised and subject to transcription errors. The journal shows that an application was accepted and advertised; it does not show what happened afterwards (registration, opposition, withdrawal or abandonment), applications not yet advertised, or marks advertised before August 2021, so this is not the live register status. Applicants may ask for a correction or removal by writing to mehak@trademarkindia.pro. Information only, not legal advice and not a solicitation.